Charles River to Acquire WIL Research

News   Jan 08, 2016

 
Charles River to Acquire WIL Research
 
 
 

RELATED ARTICLES

Peptide Medication Breakthrough

News

A research team led by the Technical University of Munich (TUM) has now determined how peptides can be designed so that they can be easily administered as a liquid or tablet.

READ MORE

High-throughput Screening: Microscale Thermophoresis to Characterize Hits

News

A new perspective article details how the European Lead Factory (ELF), a large publicly accessible drug discovery platform, uses microscale thermophoresis (MST) to aid in the prioritization of small molecule hits from high-throughput screening.

READ MORE

Lonza Expands Encapsulation and HPAPI Capabilities in North America

News

Expanding our capabilities into commercial-scale encapsulation responds to our customers' desire to maintain programs at the Tampa, FL (USA) site from clinical development to commercialization.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE